EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanistic Insights into the Adenosine A1 Receptor’s Positive Allosteric Modulation for Non-Opioid Analgesics

Tal Weizmann, Abigail Pearce, Peter Griffin, Achille Schild iD, Maren Flaßhoff, Philipp Grossenbacher iD, Martin Lochner iD, Christopher A Reynolds iD, Graham Ladds iD, Giuseppe Deganutti iD

Cells · 2024

DOI: 10.3390/cells13242121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Tal Weizmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Health and Life Sciences, Coventry University, Coventry CV1 5FB, UK. Hauptthemen laut MEDLINE: Receptor, Adenosine A1, Molecular Dynamics Simulation. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, BBSCR, Royal Society Industry Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The adenosine A1 receptor (A1R) is a promising target for pain treatment. However, the development of therapeutic agonists is hampered by adverse effects, mainly including sedation, bradycardia, hypotension, or respiratory depression. Recently discovered molecules able to overcome this impediment are the positive allosteric modulator MIPS521 and the A1R-selective agonist BnOCPA, which are both potent and powerful analgesics with fewer side effects. While BnOCPA directly activates the A1R from the canonical orthosteric site, MIPS521 binds to an allosteric site, acting in concert with orthosteric adenosine and tuning its pharmacology. Given their overlapping profile in pain models but distinct mechanisms of action, we combined pharmacology and microsecond molecular dynamics simulations to address MIPS521 and BnOCPA activity and their reciprocal influence when bound to the A1R. We show that MIPS521 changes adenosine and BnOCPA G protein selectivity in opposite ways and propose a structural model where TM7 dynamics are differently affected and involved in the G protein preferences of adenosine and BnOCPA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Adenosine A1Molecular Dynamics SimulationAllosteric RegulationHumansAdenosineAnalgesics, Non-NarcoticAdenosine A1 Receptor AgonistsAllosteric SiteAnimals

Stichwörter der Autor:innen

BnOCPAGPCRsMIPS521adenosine A1 receptornon-opioid analgesia

Substanzen

Receptor, Adenosine A1AdenosineAnalgesics, Non-NarcoticAdenosine A1 Receptor Agonists

Autor:innen und Institutionen

  • Centre for Health and Life Sciences, Coventry University, Coventry CV1 5FB, UK.
  • Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK.
  • Institute of Biochemistry and Molecular Medicine, University of Bern, 3012 Bern, Switzerland.

ORCID-Profile: Achille Schild, Philipp Grossenbacher, Martin Lochner, Christopher A Reynolds, Graham Ladds, Giuseppe Deganutti

Förderung

  • Biotechnology and Biological Sciences Research Council
  • BBSCR
  • Royal Society Industry Fellowship

Zitieren

APA

Weizmann, T., Pearce, A., Griffin, P., Schild, A., Flaßhoff, M., Grossenbacher, P., Lochner, M., Reynolds, C. A., Ladds, G., & Deganutti, G. (2024). Mechanistic Insights into the Adenosine A1 Receptor’s Positive Allosteric Modulation for Non-Opioid Analgesics. Cells. https://doi.org/10.3390/cells13242121

Vancouver

Weizmann T, Pearce A, Griffin P, Schild A, Flaßhoff M, Grossenbacher P, et al. Mechanistic Insights into the Adenosine A1 Receptor’s Positive Allosteric Modulation for Non-Opioid Analgesics. Cells. 2024. doi:10.3390/cells13242121

BibTeX
@article{Weizmann2024,
  author = {Weizmann, Tal and Pearce, Abigail and Griffin, Peter and Schild, Achille and Flaßhoff, Maren and Grossenbacher, Philipp and Lochner, Martin and Reynolds, Christopher A and Ladds, Graham and Deganutti, Giuseppe},
  title = {Mechanistic Insights into the Adenosine A1 Receptor’s Positive Allosteric Modulation for Non-Opioid Analgesics},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13242121}
}
Kostenlos starten →